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Human inducible nitric oxide synthase (iNOS) is most readily observed in macrophages from patients with inflammatory diseases like
atherosclerosis. The aim of the present study was to find out the combined effect of male sex hormone; testosterone and apocynin (NADPH
oxidase inhibitor) on cytokine-induced iNOS production. THP-1 cells were differentiated into macrophages by phorbol myristate acetate
(PMA). Expression of iNOS was induced by the addition of cytokine mixture? Testosterone was added at different concentrations (106–
1012 M) with apocynin (1 mM). Testosterone (108, 1010 M) inhibited NOx production in cytokine-added THP-1 cells which was further
confirmed by quantikine assay of iNOS protein and RT-PCR analysis. Testosterone treatment decreased 40% of superoxide anion production.
Testosterone showed inhibition of NADPH oxidase, especially expression of p67phox and p47phox (cytosol subunits). Addition of testosterone
with apocynin further decreased the expression of p67phox and p47phox subunits of NADPH oxidase. The findings of the present study
suggest that, testosterone; the male androgen plays an important role in the prevention of atherogenesis. Even though apocynin does not have
any role on NO production, addition of apocynin together with testosterone is effective in suppressing iNOS activity.
D 2004 Elsevier B.V. All rights reserved.
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Nitric oxide (NO) is a free radical gas, synthesized from
l-arginine by a family of nitric oxide synthases (NOS)
including neuronal (nNOS) inducible (iNOS) and endothe-
lial NOS (eNOS) isoforms [1]. Both nNOS and eNOS are
constitutively expressed, whereas iNOS is induced by
inflammation. Many cells including macrophages, neutro-
phils, hepatocytes and smooth muscle cells have the ability
to express iNOS. iNOS is expressed mainly in macro-
phages and its expression is regulated largely at the
transcriptional level by many factors such as cytokines,
growth factors and endotoxins [2,3]. iNOS has been0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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atherosclerotic plaques of human coronary arteries [4]. The
local release of a large amount of NOx has been linked to
the production of harmful oxidative products such as
peroxynitrite, which enhances platelet adhesion and aggre-
gation. NOx also induces vascular hyper-reactivity and
alters various proteins by nitration of their tyrosine residues
[5]. Recent data suggests that the increased production of
reactive oxygen species in the vascular wall may contribute
to the functional and structural changes associated with
atherosclerosis [6].
Atherosclerosis is one of the main causes of morbidity
and mortality in western countries [7,8]. Men have earlier
and more severe atherosclerosis than women, independent
of environmental risk factor exposure [9,10]. Sex steroids
have antioxidant capacity and reduced levels of these
hormones in elderly people may contribute to the develop-ta 1693 (2004) 185–191
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extremely high doses of anabolic steroids has been linked to
cardiac death, which led many to believe that the
physiologically high levels of androgens in men have a
deleterious effect on the male cardiovascular system [11].
However, the effect of testosterone administration has also
been reported to cause a decrease in atherosclerosis in
castrated male rabbits and in LDL-receptor knockout
(LDLR/) mice [12]. It would be important to assess
whether an optimal dose of testosterone administration
either alone or in conjunction with NADPH oxidase
inhibitor could decrease iNOS production. Therefore, the
present study was carried out to assess the combined effect
of testosterone and apocynin on superoxide and nitric oxide
production in THP-1 cell line, a suitable model of human
primary macrophages.2. Materials and methods
2.1. Materials
Phorbol myristate acetate (PMA) (Wako Osaka, Japan),
LPS, IFN-a INF-g? RPMI-1640, streptomycin, penicillin,
apocynin (4 hydroxy-3-methoxyacetophenone), testoster-
one, ICI-182780, fadrozole (aromatase inhibitor), DCFH-
DA, PCR Kit, RNA extraction Kit (Takara One-step RNA
PCR Kit, Japan) and human iNOS quantikine kit (R&D
systems iNOS quantikine kit, USA).
2.2. Cell culture
THP-1 cells of the human pre-myeloid cell were differ-
entiated from their monocyte-like state into macrophages.
For experiments, cells were grown to 70–80% confluence
and were treated as follows: briefly, THP-1 cells (2106)
were treated with 10 ng/ml of PMA for 3 days until the cells
adhered to the bottom and exhibited macrophage-like
morphology. Further, the differentiated cells were incubated
in serum and phenol red-free medium. Cytokine mixture
(LPS, TNFa and IFN-g) was added to induce iNOS.
Different concentrations of testosterone (106, 108,
1010 and 1012 M) were freshly prepared from stock
(prepared in 0.1% ethanol) using the same culture media as
the diluent. Control wells were treated with 0.1% ethanol
which was used to dissolve the sex-steroid.
2.3. Flow cytometric analysis for ROS generation
At the end of the treatment period, THP-1 cells were
washed with phosphate-buffered saline (PBS), 2 Al of 5 mM
DCFH-DA were added and then incubated in 37 8C for 30
min. Cells were detached with trypsin, and centrifuged at 4
8C, 15,000 rpm for 5 min. Cell suspensions in PBS were
transferred into 5 ml polystyrene round-bottom tubes with
cell-strainer caps (Becton-Dickinson lab ware, Becton-Dickinson and Company, France) they were kept on ice
for immediate measurement by FACS (fluorescence-acti-
vated cell sorter, BD Biosciences). Each sample was
evaluated on FACS caliber flowcytometer (Becton-Dick-
inson, USA). Fluorescence of 10,000 cells was acquired by
gating the cytokine-stimulated THP-1 cells and was
analyzed by the Cell Quest program.
2.4. Measurement of nitrite and nitrate
NOx content of the medium was measured with an
automated NO detector high-pressure liquid chromatogra-
phy system (ENO10, EICOM Kyoto, Japan) as previously
described [13]. Briefly, the supernatants were taken for
measurement of NOx by HPLC (ENO10, Eicom), where
nitrate was converted to nitrite in an in-line copper-coated
cadmium reduction column (NO-RED), and then nitrite was
detected based on Griess reaction.
2.5. Measurement of iNOS protein by quantikine assay
THP-1 cells were collected by centrifugation and washed
with PBS. The cells were lysed using lysing solution
(provided with the kit), and the supernatant was used for
iNOS protein measurement by iNOS quantikine kit. The
values were expressed as units/ml.
2.6. Western blot analysis
Total protein was extracted by adding lysis buffer (10
mM Tris (pH 7.4) 1% SDS and 1 mM sodium carbonate).
The extracted protein was quantified and 10 Ag of protein
was loaded into each lane of 12% polyacrylamide gel.
Following electrophoresis, the protein samples transferred to
PVDF membrane, blocked with 2% skimmed milk powder
and then incubated with primary antibodies (p67phox and
p47phox) for 1 h. The blots were then washed with PBS and
incubated with secondary antibody for 1 h. The membranes
were washed with PBS and dried. The band density was
measured by NIH image analyzer.
2.7. RT-PCR for NADPH oxidase
Total RNA was isolated from THP-1 cells with TRIZOL
reagent according to the manufacturer’s protocol (GIBCO
BRL, Life Technologies). Primers for amplification of
iNOS, p22phox, p47phox and p67phox were designed from
published human phagocyte sequences [14] to amplify







Fig. 1. Effect of testosterone on superoxide production in PMA-differ-
entiated cytokine-added THP-1 cells. The level of superoxide production
was significantly high in differentiated macrophages. Addition of testoster-
one has shown an inhibitory effect on superoxide production.






Anti-sense 3V-CATGGGAACACTGAGCTTCA-5VFig. 2. Effect of testosterone alone and testosterone with apocynin on NOx
and superoxide production in cytokine-stimulated THP-1 cells.2.8. Statistical analysis
The results are expressed as meanFS.D., and represent
three independent experiments and statistical analysis was
performed by Student’s t-test.3. Results
3.1. Superoxide production
We found that THP-1 cells stimulated with PMA and
cytokine mixture produced significantly higher amounts of
superoxide when compared to monocytes (Pb0.001).
Interestingly, cells treated with testosterone produced a
lesser amount of superoxides. Among various concen-
trations of testosterone used, 108 and 1010 M appeared
to be more effective than 106 and 1012 M (Pb0.001
and Pb0.01). High levels of superoxide in PMA-differ-
entiated cells suggest that differentiation of monocyte into
macrophage may enhance the activity of NADPH oxidase
(Fig. 1). Measurement of superoxide clearly shows that
addition of ethanol does not alter the NOx production. The
production of superoxide was seen to be significantly
decreased in cells treated with both testosterone and
apocynin (Fig. 2b).Fig. 3. Panels a and b show the level of NOx and iNOS protein in
testosterone-added THP-1 cells. Testosterone at the concentration of 108
and 1010 M has a capacity to inhibit NOx production.
Fig. 4. Panels a and b show the level of p47phox and p67phox expression in
fadrozole-added THP-1 cells. Fadrozole, a known aromatase inhibitor, was
added 3 h before testosterone addition and the protein was extracted and
used for Western blot. The expression of cytosolic subunits of NADPH
oxidase activity was significantly decreased in fadrozole- and testosterone-
added cells. We assume that the male sex hormone itself has a capacity to
suppress the major superoxide-producing enzyme NADPH oxidase.
Fig. 5. Panels a and b show the level of p47phox and p67phox mRNA
expression in THP-1 cells treated with testosterone alone and with both
testosterone and apocynin. The cytosolic subunits expression were
significantly low in case of cells treated with apocynin and testosterone
(108 and 1010 M).
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THP-1 cells were allowed to grow in the medium
containing testosterone alone and testosterone with apoc-
ynin. The NOx production was determined by HPLC. Our
results showed that testosterone at the concentration of 108
and 1010 M has NOx inhibiting effect. Highly significant
changes were observed in cells treated with testosterone at
the concentration of 1010 M (Fig. 3a). The cells treated
with both testosterone and apocynin produced significantly
lower amounts of NOx when compared to PMA-differ-
entiated and cytokine-induced macrophages (Fig. 2a). The
iNOS RT-PCR showed that combination of apocynin with
testosterone significantly decrease the iNOS mRNA expres-
sion (Fig. 6b).
3.3. Effect of fadrozole on superoxide production
Most of the beneficial effects of testosterone are believed
to be mediated by its conversion to estrogen. Aromatase is
the enzyme, which plays a major role in this conversion.Experiments performed with cells pretreated with fadrozole,
a known inhibitor of aromatase, followed by testosterone
addition showed a reduction in expression of p47phox and
p67phox, the major superoxide producing enzymes. The
p47phox and p67phox protein expression levels were seen to
be significantly decreased at testosterone concentrations of
108 and 1010 (Fig. 4a and b). This reduction in the
expression of p47phox and 67phox shows that testosterone
itself has the capacity to suppress the production of free
radicals.
3.4. Combined effect of testosterone and apocynin on iNOS
protein production
PMA-added (17.5F0.55) and cytokine-stimulated cells
(24.9F0.47) confirmed the successful induction of iNOS
protein in THP-1 cells, whereas levels of iNOS protein was
less in the controls (11.8F0.45). Statistically significant
increment in the iNOS level was observed in cytokine-
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monocytes. Testosterone addition showed a biphasic effect;
at concentrations of 106, 108 and 1010 M, the iNOS
levels were seen to be decreased (26.5F0.65, 22.6F0.76,
19.64F0.52, respectively), while at the concentrations of
1012 M, the iNOS level (26.22F0.25) was seen to be
increased (Fig. 3b). However, the iNOS protein level
significantly decreased addition of apocynin along with
testosterone at he concentrations of 108, 1010 and 1012
M (Pb0.001, Pb0.01 and Pb0.05) (data not shown). The
results obtained from the quantikine assay further confirmed
the NOx data by HPLC analysis.
3.5. Effect of testosterone and apocynin on NADPH oxidase
subunit mRNA expression
As shown in Fig. 5a and b, while the addition of
testosterone alone significantly decreased p47phox and
p67phox expression, testosterone in combination with apoc-
ynin decreased p47phox and p67phox mRNA expression
almost to normal as seen in monocytes (Pb0.001) (Fig. 5a
and b). RT-PCR analysis of p22phox expression showed that
testosterone alone or testosterone with apocyanin has no
effect on membrane bound subunits of NADPH oxidase
(Fig. 6a).Fig. 6. Panels a and b show the expression level of membrane bound
subunit of NADPH oxidase. The results show that addition of testosterone
or testosterone with apocynin has no effect on p22phox expression. Panel b
shows the iNOS mRNA expression by RT-PCR, which confirms the
combined effect of testosterone with apocynin.4. Discussion
Production of NOx by iNOS may be implicated in the
pathophysiological process through the formation of perox-
ynitrite, which is known to possess a strong oxidant
property and may cause cell death and tissue necrosis
within the atherosclerotic lesion. THP-1 cell line has been
successfully employed as an alternative model for primary
macrophages, since THP-1 cells exhibited changes (such as
expressing aromatase activity after differentiation into
macrophages) consistent with those we observed in primary
macrophages [15,16].
Sex hormones are thought to regulate the function of
arterial wall cells [17]. Inhibition of iNOS-induction has
been described for several steroid hormones. A shift
between the ratio of testosterone and estrogen occurs in
aging men. By the age of 40, usually testosterone levels start
to decline and estrogen levels remain relatively constant.
Estrogen inhibits iNOS and to stimulate the endothelial
constitutive NO synthase (ecNOS), resulting in a net
elevation of NOx [13]. Testosterone has also been shown
to influence the release of endothelium-derived relaxing
factor and known to act as transcription factor when bound
to the androgen receptor. Recently, the existence of
androgen receptors on human macrophages has been
described [15]. Regulation of NO release from iNOS
expressing cells predominantly occurs at the transcriptional
and/or post-transcriptional level. Testosterone therapy has
been shown to lower androgen receptor mRNA expression.
It also appears that testosterone can lower the nuclear NF-
nB in LNCaP cells [18]. However, it has been shown that
abuse of extremely high doses of anabolic steroids has been
linked to cardiac death. Our results revealed that testoster-
one at 106 M enhances NOx and iNOS protein level. Friedl
et al. [20] demonstrated that increasing concentrations of
testosterone can cause a dose-dependent inhibition of iNOS
in murine macrophages stimulated with bacterial lipopoly-
saccharide [19].
Lucigenin method is usually followed to measure
superoxide production. But recently, it has been emphasized
that high lucigenin concentrations lead to artificial O2
S
production based on redox cycling of the probe. Therefore,
in our experiment, we have adapted FACScan method, and
the results showed that addition of testosterone (108,
1010 M) diminished superoxide production. We assumed
that the antioxidant property of testosterone is responsible
for the decreased superoxide production. Studies by
Ahlbom et al. [21,22] confirmed the influence of ROS
generation and antioxidant defense by demonstrating a
twofold increase in the activity of catalase and superoxide
dismutase in cerebellar granular cells prepared from
testosterone treated rat. It has been shown that testosterone
is able to influence the ROS generation and antioxidant
defense system [23]. These research data also support our
findings that testosterone has the ability to inhibit super-
oxide production.
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and p67phox subunits were significantly decreased even after
blocking the aromatase activity by the addition of fadrozole.
As an additional experiment, we have added estrogen
receptor antagonist ICI-182780 before testosterone addition
and then the level of expression of p47phlox and p67phlox was
measured by Western blot. We have observed that blocking
of estrogen did not bring any changes in NADPH oxidase
subunit expression. Our previous study [15] demonstrated
that the NADPH oxidase and iNOS are the two major
enzymes involved in superoxide production. Guzik et al.
[23], provided the first evidence that NADPH oxidase is the
major source of O2
S in human vessels and showed an
association between enzymatic activity and clinical risk
factors for atherosclerosis. Therefore, in our study, we aimed
to find out the combined effect of testosterone and apocynin
(which is a NADPH oxidase inhibitor) in THP-1 cells.
Activation of the NADPH oxidase complex from a resting
state to full superoxide-generating activity requires the
chemical modification and translocation of additional
subunits from the cytosol to the oxidase complex on the
cell membrane. Two such important polypeptides are
p47phox and p67phox [24,25]. Moreover, the severity of
atherosclerosis correlates with NADPH oxidase subunit
mRNA expression [26]. Cytokine-stimulated macrophages
possess NADPH oxidase, a potent O2
S-generating enzyme.
O2
S rapidly inactivates NO by reacting with NO to generate
peroxynitrite, which is considered to be one of the
mechanisms leading to the development of atherosclerosis
[27]. The NADPH oxidase pathway is the major source of
superoxide generation in neutrophilic leukocytes and macro-
phages [28]. Antioxidant therapy with superoxide dismutase
in canine hemorrhagic shock or with ascorbate and a-
tocopherol in septic shock patients showed only limited
beneficial effects on cardiac function. Peroxides, such as t-
butyl peroxide and lipid peroxide, can activate NF-nB.
Cytosolic H2O2 has been shown to stimulate NF-nB-
dependent expression of platelet activating factor [29]. We
assume that apocynin use in our experiment significantly
decreased the superoxide production thereby sparing NO,
which could have prevented the production of peroxynitrite
and other toxic radicals.
In clinical studies, testosterone was found to exert both
beneficial and adverse effects on cardiovascular risk factors
and vascular function [30,31]. It has been suggested that,
with aging, other factors such as inflammation and
endogenous sex hormone levels have an increasing inde-
pendent effect on the risk of cardiovascular disease. In the
present study, we found that testosterone has biphasic
action, while exhibiting a protective effect at the optimal
concentrations to prevent oxidative damage induced by NOx
and superoxide anion. Our results are in agreement with
results of the other observational studies describing lower
levels of total and free testosterone in association with
atherosclerosis [32]. Our findings showed that the combi-
nation of testosterone and apocynin reduced the release ofsuperoxide and NOx production in PMA-differentiated and
cytokine-stimulated human monocytic THP-1 cells. Further
experiments are needed to elucidate the molecular mecha-
nisms responsible for the combined effect of testosterone
and apocynin.Acknowledgement
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